c-Myc-activated long non-coding RNA H19 downregulates miR-107 and promotes cell cycle progression of non-small cell lung cancer.

Jiandong Cui(303 Hospital of People's Liberation Army), Weiling Luo(303 Hospital of People's Liberation Army), Min Luo(Chinese Academy of Medical Sciences & Peking Union Medical College), Yu Zhang(Wannan Medical College), Tao Li(Nantong University), Shaozhang Zhou(Tumor Hospital of Guangxi Medical University), Qitao Yu(Guangxi Medical University), Juanmei Mo(303 Hospital of People's Liberation Army)
PubMed
January 1, 2015
Cited by 103

Related Papers

Epigenomic Profiling of Young and Aged HSCs Reveals Concerted Changes during Aging that Reinforce Self-Renewal
|Cell stem cell|2014|703
Exosomes derived from mesenchymal stem cells reverse EMT via TGF-β1/Smad pathway and promote repair of damaged endometrium
|Stem Cell Research & Therapy|2019|294
MicroRNA-21 down-regulates the expression of tumor suppressor PDCD4 in human glioblastoma cell T98G
|Cancer Letters|2008|216
Niraparib maintenance therapy in patients with platinum-sensitive recurrent ovarian cancer using an individualized starting dose (NORA): a randomized, double-blind, placebo-controlled phase III trial☆
|Annals of Oncology|2021|212
FOXC1-mediated LINC00301 facilitates tumor progression and triggers an immune-suppressing microenvironment in non-small cell lung cancer by regulating the HIF1α pathway
|Genome Medicine|2020|192